These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27191615)

  • 21. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
    Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
    Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a cell-based protease assay for testing inhibitors of picornavirus 3C proteases.
    van der Linden L; Ulferts R; Nabuurs SB; Kusov Y; Liu H; George S; Lacroix C; Goris N; Lefebvre D; Lanke KH; De Clercq K; Hilgenfeld R; Neyts J; van Kuppeveld FJ
    Antiviral Res; 2014 Mar; 103():17-24. PubMed ID: 24393668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
    Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
    J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro.
    Hulsebosch BM; Mounce BC
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33669273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An antiviral mechanism of nitric oxide: inhibition of a viral protease.
    Saura M; Zaragoza C; McMillan A; Quick RA; Hohenadl C; Lowenstein JM; Lowenstein CJ
    Immunity; 1999 Jan; 10(1):21-8. PubMed ID: 10023767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
    Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
    ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells.
    Lanke K; Krenn BM; Melchers WJG; Seipelt J; van Kuppeveld FJM
    J Gen Virol; 2007 Apr; 88(Pt 4):1206-1217. PubMed ID: 17374764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
    Sála M; De Palma AM; Hrebabecký H; Nencka R; Dracínský M; Leyssen P; Neyts J; Holý A
    Bioorg Med Chem; 2010 Jun; 18(12):4374-84. PubMed ID: 20576576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coxsackievirus B3 Responds to Polyamine Depletion via Enhancement of 2A and 3C Protease Activity.
    Dial CN; Tate PM; Kicmal TM; Mounce BC
    Viruses; 2019 Apr; 11(5):. PubMed ID: 31052199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway.
    Si X; McManus BM; Zhang J; Yuan J; Cheung C; Esfandiarei M; Suarez A; Morgan A; Luo H
    J Virol; 2005 Jul; 79(13):8014-23. PubMed ID: 15956547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent development of 3C and 3CL protease inhibitors for anti-coronavirus and anti-picornavirus drug discovery.
    Ramajayam R; Tan KP; Liang PH
    Biochem Soc Trans; 2011 Oct; 39(5):1371-5. PubMed ID: 21936817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of T68A/N126Y mutations on the conformational and ligand binding landscape of Coxsackievirus B3 3C protease.
    Bhakat S
    Mol Biosyst; 2015 Aug; 11(8):2303-11. PubMed ID: 26077945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiloride derivatives inhibit coxsackievirus B3 RNA replication.
    Harrison DN; Gazina EV; Purcell DF; Anderson DA; Petrou S
    J Virol; 2008 Feb; 82(3):1465-73. PubMed ID: 18032495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors.
    Webber SE; Marakovits JT; Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Srinivasan B; Moran T; Ford CE; Brothers MA; Harr JE; Meador JW; Ferre RA; Worland ST
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2683-6. PubMed ID: 11591501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D-quantitative structure-activity relationship study for the design of novel enterovirus A71 3C protease inhibitors.
    Nie Q; Xu X; Zhang Q; Ma Y; Yin Z; Shang L
    Chem Biol Drug Des; 2018 Oct; 92(4):1750-1762. PubMed ID: 29877617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.
    Muratov EN; Varlamova EV; Artemenko AG; Khristova T; Kuz'min VE; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
    Future Med Chem; 2011 Jan; 3(1):15-27. PubMed ID: 21428823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of Pyrazine-1,3-thiazine Hybrid Analogues as Antiviral Agent Against HIV-1, Influenza A (H1N1), Enterovirus 71 (EV71), and Coxsackievirus B3 (CVB3).
    Wu HM; Zhou K; Wu T; Cao YG
    Chem Biol Drug Des; 2016 Sep; 88(3):411-21. PubMed ID: 27062664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.